Pregnancy outcomes in female multiple sclerosis patients exposed to intramuscular interferon beta-1a or peginterferon beta-1a reported in a German Patient Support Programme – results from the non-interventional post-authorization safety study PRIMA

Authors
Category Primary study
JournalTherapeutic Advances in Neurological Disorders
Year 2023
This article has no abstract
Epistemonikos ID: 468fea0dc6ad585215478ddb15bcac3bd3b4af42
First added on: Feb 16, 2025